21 June 2024 - The Federal Ministers give a final decision (positive with conditions) for this trial
Trial reference:
A phase 3 multinational, open-label, systemic gene delivery study to evaluate the safety and efficacy of SRP-9003 in subjects with limb girdle muscular dystrophy 2E/R4